Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Therapeutic erythrocytapheresis"'
Autor:
Yan Ouyang, Yinyin Zhang, Huan Li, Luo Bu Zhuo Ma, Ci Ren De Ji, Chunyan Qiao, Ba Dun, Xiaodong Gao, Jun Zhu, Pengpeng Xu, Yu Zheng, Xiaoyang Li, Jianhua You, Chuanhe Jiang, Fei Yue, Junmin Li, Pu Bu Wang Dui, Kai Xue, Kai Qing
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Kidney injury from high-altitude polycythemia (HAPC) is common, yet few studies have explored effective treatments. This research assessed the renal benefits of therapeutic erythrocytapheresis (TE) in HAPC patients, analyzing the efficacy of
Externí odkaz:
https://doaj.org/article/03fc9c1002f8448d945071d6c68cfe76
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pengpeng Xu, Xiaoyang Li, Yu Zheng, Jie Fang, Ba Dun, Zong Ji, Luo Bu Zhuo Ma, Ci Ren Yang Zong, Yuexin Dong, Junmin Li, Fei Yue, Pu Bu Wang Dui
Publikováno v:
Wilderness & Environmental Medicine. 31:426-430
Introduction High altitude polycythemia (HAPC) is a common chronic disease at high altitudes. It is characterized by excessive erythrocytosis (≥190 g·L-1 in females or ≥210 g·L-1 in males). HAPC severely jeopardizes the health status of plateau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f345981a435fe606a96458ed82caffb
https://doi.org/10.1016/j.wem.2020.07.006
https://doi.org/10.1016/j.wem.2020.07.006
Publikováno v:
Acta Medica, Vol 55, Iss 4, Pp 180-185 (2012)
Background: The current treatment of hereditary hemochromatosis (HH) consists of performing periodic whole blood phlebotomies. Erythrocytapheresis (EA) can remove up to three times more red blood cells per single procedure and could thus have a clini
Externí odkaz:
https://doaj.org/article/41dcbf0180b44a39828c5202791cc2e0
Autor:
María Ángeles Montañés, Valle Recasens Flores, Ingrid Parra Salinas, José Antonio García-Erce
Publikováno v:
Medicina Clínica (English Edition). 154:16-19
Therapeutic erythrocytapheresis (TE) is a more efficient strategy compared to phlebotomy to deplete levels of haematocrit in primary and secondary erythrocytosis. Objective To analyse response rate and safety profile of TE in polycythemia vera (PV) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91bbea4ab306633511b3273120d0c8e0
https://doi.org/10.1016/j.medcle.2018.12.022
https://doi.org/10.1016/j.medcle.2018.12.022
Autor:
Bjorn Winkens, Cees Th.B.M. van Deursen, Alexander M J Rennings, E. Rombout-Sestrienkova, Mirian C. H. Janssen, Jean-Louis H. Kerkhoffs, Marian G.J. van Kraaij, Ger H. Koek, Ad A.M. Masclee, Dorothea Evers
Publikováno v:
Journal of Clinical Apheresis, 36(3), 340-347. Wiley
Journal of Clinical Apheresis, 36, 3, pp. 340-347
Journal of Clinical Apheresis
Journal of Clinical Apheresis, 36, 340-347
Journal of Clinical Apheresis, 36, 3, pp. 340-347
Journal of Clinical Apheresis
Journal of Clinical Apheresis, 36, 340-347
Contains fulltext : 234969.pdf (Publisher’s version ) (Open Access) BACKGROUND AND AIMS: Standard treatment for naïve hereditary hemochromatosis patients consists of phlebotomy or a personalized erythrocytapheresis. Erythrocytapheresis is more eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f99e240fa1632d25d264f018f996ee9
https://cris.maastrichtuniversity.nl/en/publications/8a4541ff-62e7-46e7-8eaf-d260a9da0f28
https://cris.maastrichtuniversity.nl/en/publications/8a4541ff-62e7-46e7-8eaf-d260a9da0f28
Therapeutic erythrocytapheresis (ET), and red blood cell exchange (RBCx) are procedures in which the patients' RBCs are either selectively removed (ET) or removed and replaced by allogenic donor RBCs (RBCx). ET is most commonly used for hematocrit re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f796519c01c363c86cb96c2afed138e7
https://doi.org/10.1016/b978-0-12-813726-0.00076-3
https://doi.org/10.1016/b978-0-12-813726-0.00076-3
Publikováno v:
Transfusion and Apheresis Science. 47:295-299
We investigated the correlation between body weight index (BWI) and the effective power of erythrocytapheresis in patients with polycythemia vera (PV) who received therapeutic erythrocytapheresis (TEA). Furthermore, the risk factors of the adverse ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d12b75ddfdaa606d54ccea87c5fc70e
https://doi.org/10.1016/j.transci.2012.07.017
https://doi.org/10.1016/j.transci.2012.07.017
Autor:
Paulus A.H. van Noord, Bob J.P.H. Sybesma, Ger H. Koek, Cees Th.B.M. van Deursen, Ans E.L. Nillesen-Meertens, Eva Rombout-Sestrienkova
Publikováno v:
Transfusion and Apheresis Science, 36(3), 261-267. Elsevier Limited
Hereditary Hemochromatosis (HH) is a genetic disorder of iron metabolism, resulting in excessive iron overload. Currently, phlebotomy is the standard effective treatment that prevents progression of tissue damage. Aim of the therapy is to reach ferri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35dcbbc2e218ebef60ab8e30e206b2d5
https://doi.org/10.1016/j.transci.2007.03.005
https://doi.org/10.1016/j.transci.2007.03.005
Autor:
Nidhi Mehta
Publikováno v:
Transfusion Update
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd8bba5192e6fd4557cec9529d192bfc
https://doi.org/10.5005/jp/books/12449_38
https://doi.org/10.5005/jp/books/12449_38